Erector Spinae Block in Management of Herpes Zoster Pain

Role Of Ultrasound Guided Erector Spinae Plane Block In Management Of Herpes Zoster Pain And Incidence Of Post-herpetic Neuralgia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201905893503298

Enrollment

Registered

2019-05-27

Start date

2019-06-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes Zoster

Interventions

Erector Spinae Plane Block and Standard Treatment

Standard Treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Moderate pain, Visual Analog Scale (VAS) = 4 less than 5 affected dermatomes. thoracic eruption < 3 months.

Exclusion criteria

Exclusion criteria: ASA status IV, V. coagulation abnormalities known allergy to methylprednisolone or bupivacaine serum creatinine = 5 mg/dL Patients coming after = 3 months after rash healing. chronic pain for any other reason requiring analgesia.

Design outcomes

Primary

Measure	Time frame
pain relief	—

Secondary

Measure	Time frame
post herpetic neuralgia;average dose of Pregabalin and Acetaminophen consumed ;serum interleukin-6	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026